Want to join the conversation?
$LLY 2Q15 Call: In emerging markets, revenue declined 15% driven by negative FX of 12%. On a performance basis, emerging market sales declined 4% driven by lower sales in China and the negative effect of the Brazil Humulin tender LLY had last year. This quarter, Pharma revenue in China declined 16% driven by lower volume.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.